MARKET

IMCR

IMCR

Immunocore Holdings Plc
NASDAQ
34.21
+0.01
+0.03%
After Hours: 34.00 -0.21 -0.61% 19:34 08/14 EDT
OPEN
34.02
PREV CLOSE
34.20
HIGH
34.39
LOW
33.50
VOLUME
195.19K
TURNOVER
--
52 WEEK HIGH
40.71
52 WEEK LOW
27.56
MARKET CAP
1.76B
P/E (TTM)
-92.8358
1D
5D
1M
3M
1Y
5Y
1D
How Investors May Respond To Immunocore (IMCR) Turning First-Half Profit Amid Recent Share Price Pullback
Simply Wall St · 2d ago
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM) and Immunocore Holdings (IMCR)
TipRanks · 4d ago
IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum
NASDAQ · 5d ago
Weekly Report: what happened at IMCR last week (0803-0807)?
Weekly Report · 6d ago
Immunocore Holdings (IMCR) Posted Strong Earnings, Is The 49% Undervaluation Case Convincing?
Simply Wall St · 6d ago
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Immunocore Holdings (IMCR)
TipRanks · 6d ago
Immunocore (IMCR) Stock Nears Breakeven While KIMMTRAK Risk Still Dominates
Simply Wall St · 08/08 00:39
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues
NASDAQ · 08/07 17:27
More
About IMCR
Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a pipeline of clinical-stage programs in oncology and infectious diseases, as well as numerous pre-clinical projects. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-M113V, IMC-I109V, IMC-S118AI, and IMC-U120AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, ovarian, lung, colorectal and others.

Webull offers Immunocore Holdings PLC - ADR stock information, including NASDAQ: IMCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMCR stock methods without spending real money on the virtual paper trading platform.